Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters

International Journal of Urology

Volumn 9, Issue 10, 2002, Pages 554-559

  Hirayama, Akihide ^a   Samma, Shoji ^a   Fujimoto, Ken ^a   Yamaguchi, Akira ^a   Akiyama, Tatsuya ^a   Fukui, Yoshihisa ^a  

^a National Hospital Organization   (Japan)

Author keywords

Detrusor contractility; Pressure flow study; Small prostate; Urinary disturbance outflow obstruction

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DETRUSOR MUSCLE; FLOW MEASUREMENT; HUMAN; INTERVIEW; MALE; MICTURITION DISORDER; MUSCLE CONTRACTILITY; ORGAN WEIGHT; PREDICTION; PRESSURE; PRIORITY JOURNAL; PROSTATE; QUALITY OF LIFE; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT DISEASE; URINARY TRACT OBSTRUCTION; COMPARATIVE STUDY; ECHOGRAPHY; HISTOLOGY; METHODOLOGY; MIDDLE AGED; MORPHOMETRICS; PHYSIOLOGY; PREDICTION AND FORECASTING; URODYNAMICS; UROLOGIC EXAMINATION;

AGED; AGED, 80 AND OVER; BODY WEIGHTS AND MEASURES; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; URINATION DISORDERS; URODYNAMICS;

EID: 0036436167     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00524.x     Document Type: Article

References (23)

1. Chancellor MB, Rivas DA. American Urological Association Symptom Index for women with voiding symptoms: Lack of index specificity for benign prostate hyperplasia. J. Urol. 1993;150: 1706-9.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J. Urol. 1984;132: 474-9.
3. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br. J. Urol. 1979;51: 129-34.
4. Ameda K, Sullivan MP, Bae RJ, Yalla SV. Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly man. J. Urol. 1999; 162: 142-6.
5. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J. Urol. 1995;154: 1764-9.
6. Schäfer W. Analysis active detrusor function during voiding with the bladder working function. Neurourol. Urodyn. 1991;10: 19-35.
7. Griffiths D, Höfner K, van Mastrigt R, Rollema HJ, Spangberg A, Gleason D. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and outflow obstruction. Neurourol. Urodyn. 1997;16: 1-18.
8. Janknegt RA. Surgical management for benign prostatic hyperplasia: Indications, techniques, results. Prostate Suppl. 1989;2: 79-93.
9. Nasu K, Moriyama N, Kawabe K et al. Quantification and distribution of a-1-adrenoceptor subtype mRNAs in human prostate: Comparison of benign hypertrophied tissue and non-hypertrophied tissue. Br. J. Pharmacol. 1996;119: 797-803.
10. McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol. Clin. North Am. 1990; 17: 477-86.
11. Ghoniem GM. Impaired bladder contractility in association with detrusor instability: Underestimated occurrence in benign prostatic hyperplasia. Neurourol. Urodyn. 1991;10: 111-8.
12. Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG. Correlation of American Urological Association Symptom Index with obstructive and nonobstructive prostatism. J. Urol. 1995;153: 674-80.
13. Levin RM, Longhurst PA, Monson FC, Kato K, Wein AJ. Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladder. Prostate Suppl. 1990;3: 9-26.
14. Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y. Urinary symptoms and urodynamics in a normal elderly population. Scand.J. Urol. Nephrol. Suppl. 1994;157: 27-30.
15. Chancellor MB, Rivas DA, Keeley FX, Lotfi MA, Gomella LG. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Br. J. Urol. 1994;74: 200-3.
16. Barry MJ, O'Leary MP. The development and clinical utility of symptom scores. Urol. Clin. North Am. 1995;22: 299-307.
17. Schäfer W. Principles and clinical application of advanced urodynamic analysis of voiding function. Urol. Clin. North Am. 1990;17: 553-66.
18. Marks LS, Partin AW, Gormley GJ et al. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J. Urol. 1997;157: 2171-8.
19. Schäfer W, Noppeney R, Rübben HT, Lutzeyer W. The value of free flow rate and pressure/flow-studies in the routine investigation of BPH patients. Neurourol. Urodyn. 1988;7: 219-21.
20. McLoughlin J, Gill KP, Abel PD, Williams G. Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br. J. Urol. 1990;66: 303-5.
21. Chancellor MB, Blaivas JG, Kaplan SA, Axelrod S. Bladder outlet obstruction versus impaired detrusor contractility: The role of uroflow. J. Urol. 1991; 145: 810-2.
22. Javle P, Jenkins SA, Machin DG, Parsons KF. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy. J. Urol. 1998; 160: 1713-7.
23. Couillard DR, Webster GD. Detrusor instability. Urol. Clin. North Am. 1995;22: 593-612.